Inventor · disambiguated record
Marcus F. Boehm
Also filed as: BOEHM MARCUS · BOEHM MARCUS F
64 granted patents·38 pending applications·890 citations·filing 1993–2024
99Inventor score
Files withESCIENT PHARMACEUTICALS INC22CONFORMA THERAPEUTICS CORP21LIGAND PHARM INC16RECEPTOS INC14BOEHM MARCUS F5
Top patents by PatentIndex Score
102 records- 0195US7138401B22-aminopurine analogs having HSP90-inhibiting activityCONFORMA THERAPEUTICS CORP·Filed 2004·Granted Nov 21, 2006·60 cites·46 claims
- 0295US5780676ACompounds having selective activity for Retinoid X Receptors, and means for modulation of processes mediated by Retinoid X ReceptorsLIGAND PHARM INC·Filed 1995·Granted Jul 14, 1998·81 cites·23 claims
- 0394US11919864B2Modulators of Mas-related G-protein receptor X2 and related products and methodsESCIENT PHARMACEUTICALS INC·Filed 2021·Granted Mar 5, 2024·3 cites·52 claims
- 0494US11667636B2Modulators of Mas-related G-protein receptor X2 and related products and methodsESCIENT PHARMACEUTICALS INC·Filed 2021·Granted Jun 6, 2023·3 cites·32 claims
- 0593US7241890B2Purine analogs having HSP90-inhibiting activityCONFORMA THERAPEUTICS CORP·Filed 2002·Granted Jul 10, 2007·93 cites·5 claims
- 0691US7148228B2Pyrazolopyrimidines and related analogs as HSP90-inhibitorsCONFORMA THERAPEUTICS CORP·Filed 2004·Granted Dec 12, 2006·35 cites·51 claims
- 0789US11952346B2Modulators of mas-related G-protein receptor X2 and related products and methodsESCIENT PHARMACEUTICALS INC·Filed 2021·Granted Apr 9, 2024·1 cites·11 claims
- 0889US10259823B2GLP-1 receptor modulatorsCELGENE INT II SARL·Filed 2017·Granted Apr 16, 2019·7 cites·26 claims
- 0989US9388147B2Selective sphingosine 1 phosphate receptor modulators and methods of chiral synthesisRECEPTOS INC·Filed 2015·Granted Jul 12, 2016·9 cites·36 claims
- 1089US5962731ACompounds having selective activity for retinoid X receptors, and means for modulation of processes mediated by retinoid X receptorsLIGAND PHARM INC·Filed 1995·Granted Oct 5, 1999·30 cites·26 claims
- 1189US5721103ATrienoic retinoid compounds and methodsLIGAND PHARM INC·Filed 1995·Granted Feb 24, 1998·35 cites·39 claims
- 1288US11970452B2Modulators of mas-related G-protein receptor X2 and related products and methodsESCIENT PHARMACEUTICALS INC·Filed 2021·Granted Apr 30, 2024·1 cites·4 claims
- 1388US8362048B2Selective sphingosine 1 phosphate receptor modulators and methods of chiral synthesisRECEPTOS INC·Filed 2010·Granted Jan 29, 2013·10 cites·24 claims
- 1487US9839664B2GLP-1 receptor modulatorsCELGENE INT II SÀRL·Filed 2016·Granted Dec 12, 2017·8 cites·34 claims
- 1587US8816121B2GLP-1 receptor stabilizers and modulatorsRECEPTOS INC·Filed 2013·Granted Aug 26, 2014·10 cites·44 claims
- 1687US8778923B2GLP-1 receptor modulatorsRECEPTOS INC·Filed 2012·Granted Jul 15, 2014·11 cites·12 claims
- 1786US9474755B2GLP-1 receptor modulatorsRECEPTOS INC·Filed 2015·Granted Oct 25, 2016·6 cites·80 claims
- 1886US9260427B2GLP-1 receptor modulatorsRECEPTOS INC·Filed 2014·Granted Feb 16, 2016·8 cites·57 claims
- 1986US8501982B2GLP-1 receptor stabilizers and modulatorsBOEHM MARCUS F·Filed 2011·Granted Aug 6, 2013·11 cites·48 claims
- 2086US7138402B2Pyrrolopyrimidines and related analogs as HSP90-inhibitorsCONFORMA THERAPEUTICS CORP·Filed 2004·Granted Nov 21, 2006·23 cites·68 claims
- 2186US6218430B1Vitamin D3 mimicsLIGAND PHARM INC·Filed 1998·Granted Apr 17, 2001·84 cites·38 claims
- 2285US12129243B2Modulators of Mas-related G-protein receptor X2 and related products and methodsESCIENT PHARMACEUTICALS INC·Filed 2023·Granted Oct 29, 2024·0 cites·11 claims
- 2385US9278910B2GLP-1 receptor stabilizers and modulatorsBOEHM MARCUS F·Filed 2012·Granted Mar 8, 2016·9 cites·8 claims
- 2485US9187522B2GLP-1 receptor modulatorsRECEPTOS INC·Filed 2014·Granted Nov 17, 2015·7 cites·16 claims
- 2584US12129244B2Modulators of Mas-related G-protein receptor X2 and related products and methodsESCIENT PHARMACEUTICALS INC·Filed 2023·Granted Oct 29, 2024·0 cites·36 claims
- 2684US9700543B2GLP-1 receptor stabilizers and modulatorsCELGENE INT II SÀRL·Filed 2016·Granted Jul 11, 2017·5 cites·8 claims
- 2784US8357706B2Sphingosine 1 phosphate receptor modulators and methods of chiral synthesisRECEPTOS INC·Filed 2010·Granted Jan 22, 2013·6 cites·31 claims
- 2884US7129244B2Triazolopyrimidines and related analogs as HSP90-inhibitorsCONFORMA THERAPEUTICS CORP·Filed 2004·Granted Oct 31, 2006·13 cites·21 claims
- 2984US2025026735A1Modulators of mas-related g-protein receptor x2 and related products and methodsESCIENT PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 3083US7465718B2Ansamycins having improved pharmacological and biological propertiesCONFORMA THERAPEUTICS CORP·Filed 2003·Granted Dec 16, 2008·27 cites·23 claims
- 3181US12384748B2Modulators of mas-related g-protein receptor X2 and related products and methodsESCIENT PHARMACEUTICALS INC·Filed 2024·Granted Aug 12, 2025·0 cites·10 claims
- 3281US8507538B2Selective heterocyclic sphingosine 1 phosphate receptor modulatorsBOEHM MARCUS F·Filed 2010·Granted Aug 13, 2013·5 cites·59 claims
- 3381US6083977ATrienoic retinoid compounds and methodsLIGAND PHARM INC·Filed 1995·Granted Jul 4, 2000·20 cites·37 claims
- 3481US2025289815A1Modulators of mas-related g-protein receptor x2 and related products and methodsESCIENT PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 3580US10239846B2Selective sphingosine 1 phosphate receptor modulators and methods of chiral synthesisCELGENE INT II SARL·Filed 2017·Granted Mar 26, 2019·2 cites·10 claims
- 3680US6593493B1RXR modulators with improved pharmacologic profileLIGAND PHARM INC·Filed 2000·Granted Jul 15, 2003·16 cites·85 claims
- 3780US5998654ARetinoic acid receptor antagonist compounds and methodsLIGAND PHARM INC·Filed 1997·Granted Dec 7, 1999·21 cites·29 claims
- 3880US2024300907A1Modulators of mas-related g-protein receptor x4 and related products and methodsESCIENT PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 3980US2024059667A1Modulators of mas-related g-protein receptor x2 and related products and methodsESCIENT PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 4078US7348359B2Retinoid X receptor modulatorsLILLY CO ELI·Filed 2002·Granted Mar 25, 2008·11 cites·37 claims
- 4178US6043279ACompounds having selective activity for retinoid X receptors, and means for modulation of processes mediated by retinoid X receptorsLIGAND PHARM INC·Filed 1997·Granted Mar 28, 2000·16 cites·13 claims
- 4276US12275707B2Modulators of mas-related g-protein receptor X2 and related products and methodsESCIENT PHARMACEUTICALS INC·Filed 2023·Granted Apr 15, 2025·0 cites·42 claims
- 4376US12240845B2Modulators of mas-related G-protein receptor X2 and related products and methodsESCIENT PHARMACEUTICALS INC·Filed 2023·Granted Mar 4, 2025·0 cites·41 claims
- 4476US11840521B2Modulators of Mas-related G-protein receptor X4 and related products and methodsESCIENT PHARMACEUTICALS INC·Filed 2022·Granted Dec 12, 2023·0 cites·32 claims
- 4576US7544672B2Alkynyl pyrrolo[2,3-d]pyrimidines and related analogs as HSP90-inhibitorsCONFORMA THERAPEUTICS CORP·Filed 2006·Granted Jun 9, 2009·3 cites·13 claims
- 4676US7056954B2Means for the modulation of processes mediated by retinoid receptors and compounds useful thereforLIGAND PHARM INC·Filed 2003·Granted Jun 6, 2006·3 cites·2 claims
- 4776US5990163ASelective modulation of processes mediated by retinoid X receptors, and compounds useful thereforSALK INST FOR BIOLOGICAL STUDI·Filed 1995·Granted Nov 23, 1999·51 cites·16 claims
- 4874US2024239749A1Modulators of mas-related g-protein receptor x2 and related products and methodsESCIENT PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 4973US11643399B2Modulators of mas-related G-protein receptor X4 and related products and methodsESCIENT PHARMACEUTICALS INC·Filed 2021·Granted May 9, 2023·0 cites·23 claims
- 5073US10034886B2GLP-1 receptor modulatorsCELGENE INT II SARL·Filed 2017·Granted Jul 31, 2018·1 cites·14 claims
Showing the top 50 of 102 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Marcus F. Boehm files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →